Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report

BACKGROUND: Gemcitabine and cisplatin are chemotherapeutic agents used for treating multiple cancers, and these agents are sometimes used in combination. Drug-induced thrombotic microangiopathy (TMA) is a rare but potentially fatal complication. It typically presents as a systemic disease with the c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Nephrol
Autori principali: Nishikubo, Masashi, Shimomura, Yoshimitsu, Hiramoto, Nobuhiro, Sawamura, Naohiko, Yamaguchi, Takako, Hara, Shigeo, Ishikawa, Takayuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114690/
https://ncbi.nlm.nih.gov/pubmed/33980166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-021-02386-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi